Sponsor / Institution

Erasmus MC

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All Programs Therapeutics Devices

Open filtered programs

Programs

linked to organization

Strong Evidence

0 status confirmed

Details Checked

0 open data checks

Company / Institution Links

0 / 1

industry vs non-industry records

Competitive Density

Pipeline Velocity

100

Completion Signal

100

Programs by Stage

Phase 31

Trial / Program Status

Active1

Modality Mix

Drug Delivery1

Indication Coverage

Cisplatin-Induced Hearing Loss1

Hearing Loss1

Ototoxicity1

Sensorineural Hearing Loss1

Program Types

Therapeutic1

Population Tags

adult1

cisplatin-ototoxicity1

head-and-neck-cancer1

otoprotection1

Strong-Evidence Records

0 records

No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks

NKI SOUND transtympanic sodium thiosulfate cisplatin otoprotection study

Details checked

Drug DeliveryPhase 3Active

Transtympanic sodium thiosulfate gel injected into one ear before cisplatin infusion to locally prevent cisplatin-induced sensorineural hearing loss while using the untreated contralateral ear as comparator.

Data checks: institution-led-study, registry-only-evidence